Slump in medtech VC activity continues
Other Languages
Recognized by Forbes
Top 150
America's Best Executive Recruiting Firms.




Orthopedic markets to return to normal this year as post-pandemic boost fades


Medical device companies are in an ‘emerging bull market,’ Jim Cramer says


Med-tech financings April 2023


Maximizing M&A Value: Avoiding Common Mistakes by Sellers

Medtech’s top R&D spenders and the projects they launched

Don't Let the Ghost of Spine Deals Past Spook Future Deals


Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report

Medtech earnings highlights: Easing of macro pressures, accelerated growth in 2023

Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound

Artificial intelligence could save healthcare industry $360B a year

9 Key Investor Milestones Every Med Device Developer Should Know

Digital health outlook: trends to watch in 2023

Medtech companies start 2023 on ‘optimistic’ note amid earnings forecasts, staffing: J.P. Morgan

‘Mixed signals’ from medtech management suggest industry had bumpy end to 2022: analysts

PitchBook Analyst Note: Takeaways From the 2023 J.P. Morgan Healthcare Conference:

How Companies Can Thrive in Today’s Medtech Environment

North America’s medical devices industry saw a drop of 38.60% in deal activity during November 2022

The biggest medtech stock gainers, losers in 2022

A look back at medtech’s top 10 acquisitions of 2022